Literature DB >> 23595615

Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.

Shadman Nemati1, Rasool Hassanzadeh, Sina Khajeh Jahromi, Azimeh Delkhosh Nasrollah Abadi.   

Abstract

Otomycosis as a kind of external otitis can be caused by various species of fungi. To use the appropriate treatment, it is necessary to identify the causal agent of otomycosis. The aim of this study was to determine the pathogens that caused otomycosis and also the efficacy of different antifungal agents. 100 patients with diagnosis of otomycosis/otitis extern were entered in this study. Bacterial culture was performed by eosin methylene blue agar, blood agar; and Sabouraud dextrose agar was used to culture the fungal agents. Minimum inhibitory concentration test also was performed to determine the efficacy of Clotrimazole, Fluconazole, Ketoconazole and Nystatin on the fungal pathogens. Otomycosis was confirmed in 43% of patients by positive culture. The most prevalent fungal pathogen was Aspergillus niger which was sensitive to Clotrimazole, Fluconazole, Ketoconazole. Candida albicans was sensitive to all drugs, in which, the most sensitivity was due to fluconazole. The most frequent fungal pathogen in our otomycosis cases is A. niger, and most of fungi that caused otomycosis are sensitive to clotrimazole.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23595615     DOI: 10.1007/s00405-013-2486-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  19 in total

1.  Otomycosis: prevalence, clinical symptoms, therapeutic procedure.

Authors:  P Kurnatowski; A Filipiak
Journal:  Mycoses       Date:  2001-12       Impact factor: 4.377

2.  Treatment outcome of otomycosis in Ilorin, Nigeria.

Authors:  F E Ologe; C Nwabuisi
Journal:  West Afr J Med       Date:  2002 Jan-Mar

3.  Otomycosis due to filamentous fungi.

Authors:  Lidia García-Agudo; Pilar Aznar-Marín; Fátima Galán-Sánchez; Pedro García-Martos; Pilar Marín-Casanova; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2011-04-17       Impact factor: 2.574

4.  Otomycosis in Turkey: predisposing factors, aetiology and therapy.

Authors:  K Murat Ozcan; Muge Ozcan; Aydin Karaarslan; Filiz Karaarslan
Journal:  J Laryngol Otol       Date:  2003-01       Impact factor: 1.469

5.  Otomycosis: clinical features and treatment implications.

Authors:  Tang Ho; Jeffrey T Vrabec; Donald Yoo; Newton J Coker
Journal:  Otolaryngol Head Neck Surg       Date:  2006-11       Impact factor: 3.497

6.  Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Authors:  Bibhu Pradhan; Nhuchhe Ratna Tuladhar; Ramchaya Man Amatya
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-04       Impact factor: 1.547

7.  Otomycosis in São Paulo.

Authors:  L Zaror; O Fischman; F A Suzuki; R G Felipe
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1991 May-Jun       Impact factor: 1.846

8.  Broad spectrum antifungal agents in otomycosis.

Authors:  A Bassiouny; T Kamel; M K Moawad; D S Hindawy
Journal:  J Laryngol Otol       Date:  1986-08       Impact factor: 1.469

9.  [The observation of mycology and clinical efficacy in 325 cases with otomycosis].

Authors:  H Nong; J Li; G Huang; D Nong; P Cheng; C Yao
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  1999-10

10.  Otomycosis: a retrospective study.

Authors:  Zélia Braz Vieira da Silva Pontes; Anna Débora Ferreira Silva; Edeltrudes de Oliveira Lima; Márcio de Holanda Guerra; Neuza Maria Cavalcanti Oliveira; Maria de Fátima Farias Peixoto Carvalho; Felipe Sarmento Queiroga Guerra
Journal:  Braz J Otorhinolaryngol       Date:  2009 May-Jun
View more
  11 in total

Review 1.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

2.  Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

Authors:  Keyvan Kiakojuri; Saeid Mahdavi Omran; Somayeh Roodgari; Mojtaba Taghizadeh Armaki; Mohammad Taghi Hedayati; Tahereh Shokohi; Iman Haghani; Javad Javidnia; Firoozeh Kermani; Hamid Badali; Mahdi Abastabar
Journal:  Mycopathologia       Date:  2021-03-15       Impact factor: 2.574

3.  Sertaconazole versus Clotrimazole and Miconazole Creams in the Treatment of Otomycosis: A Placebo-Controlled Clinical Trial.

Authors:  Shadman Nemati; Hooshang Gerami; Ali Faghih Habibi; Ehsan Kazemnejad; Noushin Shabani; Vahid Aghsaghloo; Sina Montazeri
Journal:  Iran J Otorhinolaryngol       Date:  2022-01

4.  Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran.

Authors:  Keivan Kiakojuri; Ramazan Rajabnia; Bahareh Jalili; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

5.  Lamisil, a potent alternative antifungal drug for otomycosis.

Authors:  A Zarei Mahmoudabadi; Z Seifi; M Gharaghani
Journal:  Curr Med Mycol       Date:  2015-03

6.  Investigation of Etiologic Agents and Clinical Presentations of Otomycosis at a Tertiary Referral Center in Tehran, Iran.

Authors:  Hasti Kamali Sarwestani; Roshanak Daie Ghazvini; Seyed Jamal Hashemi; Sassan Rezaie; Mohsen Gerami Shoar; Shahram Mahmoudi; Miad Elahi; Ardavan Tajdini
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

7.  Assessment of Response to Treatment in Patients with Otomycosis.

Authors:  Keyvan Kiakojori; Nasim Bagherpour Jamnani; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Iran J Otorhinolaryngol       Date:  2018-01

8.  Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis.

Authors:  Saeid Mahdavi Omran; Zahra Yousefzade; Soraya Khafri; Mojtaba Taghizadeh-Armaki; Keyvan Kiakojuri
Journal:  Curr Med Mycol       Date:  2018-03

9.  Role of Clotrimazole in Prevention of Recurrent Otomycosis.

Authors:  Keyvan Kiakojuri; Ramazan Rajabnia; Saeid Mahdavi Omran; Abazar Pournajaf; Mohsen Karami; Mojtaba Taghizadeh Armaki
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

10.  Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.

Authors:  Maral Gharaghani; Marzieh Halvaeezadeh; Gholam Ali Jalaee; Simin Taghipour; Neda Kiasat; Ali Zarei Mahmoudabadi
Journal:  Curr Med Mycol       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.